Justice D. Hari Paranthaman launching the book “Facts and Solution to this Menace” during an event in Chennai on Saturday. | Photo Credit: SPECIAL ARRANGEMENT The Tamil Nadu Health Development Association (TNHDA) has demanded that the State government should release a white paper about Sreesan Pharmaceuticals, manufacturer of Coldrif cough syrup linked to the deaths of several children in Madhya Pradesh in October 2025, and its operations in Tamil Nadu. Releasing a report on “Prevention of Adulterated and Spurious Drugs” on Saturday, TNHDA and the report’s author P.B. Suresh Babu, advocate, Madras High Court, demanded a white paper on the Coldrif issue. It may be recalled that the samples of the syrup, which was manufactured at Sreesan Pharmaceutical’s facility in Kancheepuram, were found to be contaminated with Diethylene Glycol, a toxic substance. Published – March 14, 2026 11:50 pm IST Share this: Click to share on WhatsApp (Opens in new window) WhatsApp Click to share on Facebook (Opens in new window) Facebook Click to share on Threads (Opens in new window) Threads Click to share on X (Opens in new window) X Click to share on Telegram (Opens in new window) Telegram Click to share on LinkedIn (Opens in new window) LinkedIn Click to share on Pinterest (Opens in new window) Pinterest Click to email a link to a friend (Opens in new window) Email More Click to print (Opens in new window) Print Click to share on Reddit (Opens in new window) Reddit Click to share on Tumblr (Opens in new window) Tumblr Click to share on Pocket (Opens in new window) Pocket Click to share on Mastodon (Opens in new window) Mastodon Click to share on Nextdoor (Opens in new window) Nextdoor Click to share on Bluesky (Opens in new window) Bluesky Like this:Like Loading... Post navigation Corporation mulling community kitchens to ensure food: Mayor Water supply to be disrupted in city wards